NioCorp Developments Ltd Common Stock (NB) had the highest return between March 1, 2023 and April 30, 2023 by a small-cap US stock, returning 652,122.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
NioCorp Developments Ltd Common Stock (NB) | 3/1/2023 - 4/30/2023 | 652,122.22% |
Pulse Biosciences (PLSE) | 3/1/2023 - 4/30/2023 | 143.94% |
WW International, Inc Common Stock (WW) | 3/1/2023 - 4/30/2023 | 127.52% |
American Coastal Insurance (ACIC) | 3/1/2023 - 4/30/2023 | 117.36% |
Eyepoint Pharmaceuticals (EYPT) | 3/1/2023 - 4/30/2023 | 86.9% |
Neurogene (NGNE) | 3/1/2023 - 4/30/2023 | 72% |
Arlo Technologies (ARLO) | 3/1/2023 - 4/30/2023 | 69.47% |
Xeris Pharmaceuticals (XERS) | 3/1/2023 - 4/30/2023 | 66.18% |
ThredUp (TDUP) | 3/1/2023 - 4/30/2023 | 66.04% |
Aquestive Therapeutics (AQST) | 3/1/2023 - 4/30/2023 | 65.58% |
Arcturus Therapeutics (ARCT) | 3/1/2023 - 4/30/2023 | 65.14% |
Crawford (CRD.A) | 3/1/2023 - 4/30/2023 | 61.83% |
Y mAbs Therapeutics (YMAB) | 3/1/2023 - 4/30/2023 | 56.81% |
Bit Digital (BTBT) | 3/1/2023 - 4/30/2023 | 54.69% |
Ardelyx (ARDX) | 3/1/2023 - 4/30/2023 | 53.26% |
Cimpress (CMPR) | 3/1/2023 - 4/30/2023 | 48.39% |
Amprius Technologies (AMPX) | 3/1/2023 - 4/30/2023 | 47.95% |
Tourmaline Bio (TRML) | 3/1/2023 - 4/30/2023 | 47.69% |
DRDGOLD Limited ADR (DRD) | 3/1/2023 - 4/30/2023 | 47.13% |
Crawford (CRD.B) | 3/1/2023 - 4/30/2023 | 47.04% |
Trevi Therapeutics (TRVI) | 3/1/2023 - 4/30/2023 | 46.38% |
Potbelly (PBPB) | 3/1/2023 - 4/30/2023 | 45.96% |
Corvus Pharmaceuticals (CRVS) | 3/1/2023 - 4/30/2023 | 45.95% |
Sana Biotechnology (SANA) | 3/1/2023 - 4/30/2023 | 44.54% |
Cipher Mining (CIFR) | 3/1/2023 - 4/30/2023 | 44.38% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
